Podcast series

 

ecnp-stamp-podcast-white

The ECNP podcast series brings you conversations with some of the leading researchers in applied neuroscience, discussing their work, their career, their vision on the field, and why they do what they do.

A big thanks to the Early Career Advisory Panel (ECAP) for the creation of the ECNP podcast series.

The first podcast is with David Nutt, United Kingdom. Additional episodes are currently in the making, with the next episode due to be released on 1 June 2021.

Pilot episode – On career, research, and the renaissance of psychedelics*
Duration: 36 min

ECNP podcast series31 March 2021 – David Nutt, United Kingdom, a leading expert in neuropsychopharmacology, shares his thoughts about the major findings in brain science and the future of psychiatry. He also talks about his curious path as a psychiatrist-turned-researcher and a fierce advocate for evidence-based treatments and policies.

*Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Interviewed
: David Nutt, United Kingdom
david-nuttDavid Nutt, DM, FRCP, FRCPsych, FMedSci, DLaws, is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London. To study the effects of drugs in the brain he uses state of the art techniques such as brain imaging with PET and fMRI plus EEG and MEG. This research output has led to over 500 original research papers outs him in the top 0.1% of researchers in the world. He has also published a similar number of reviews and books chapters, eight government reports on drugs and 35 books, including one for the general public, Drugs: without the hot air, that won the Transmission Prize in 2014. He was previously President of the European Brain Council, the British Association of Psychopharmacology, the British Neuroscience Association and the European College of Neuropsychopharmacology. He is currently Founding Chair of DrugScience.org.uk and holds visiting Professorships at the Open University and University of Maastricht. David broadcasts widely to the general public both on radio and television. In 2010 The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist in the list. In 2013 he was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science and in 2017 a Doctor of Laws hon causa from the University of Bath.

Interviewer: Aiste Lengvenyte, Lithuania
Aiste LengvenyteAiste Lengvenyte is a psychiatrist working as Chef de Clinique et Assistant des Hopitaux in Montpellier, France. She studied medicine in Lithuanian University of Health Sciencies, Lithuania, and later completed her training in psychiatry in Vilnius University, Lithuania. During her studies, she has spent time in Cagliari, Italy, Montpellier, France, and London, United Kingdom. Concurrently with her clinical work, she is undertaking a PhD project on suicidal behaviours. She is interested in biological bases of suicidal behaviours and mood disorders, as well as the best ways to address these issues. Since 2019 she is a member of ECNP’s Early Career Advisory Panel (ECAP).